Power wheelchair — group 2 denied for missing prior authorization by UnitedHealthcare?

Under UnitedHealthcare's Commercial medical policy, mobility devices including manual wheelchairs, electric wheelchairs, transfer chairs, scooters/power-operated vehicles (POV), canes, and walkers are a covered health care service when medically necessary. The policy aligns with CMS LCD L33789, which establishes that the beneficiary must have a mobility limitation that significantly impairs his/her ability to participate in one or more mobility-related activities of daily living (MRADLs) such as toileting, feeding, dressing, grooming, and bathing in customary locations in the home — a limitation that prevents the beneficiary from accomplishing an MRADL entirely, places the beneficiary at heightened risk of morbidity or mortality, or prevents completing an MRADL within a reasonable time frame ; additionally, the mobility limitation cannot be sufficiently and safely resolved by an appropriately fitted cane or walker, and the beneficiary does not have sufficient upper extremity function to self-propel an optimally-configured manual wheelchair in the home to perform MRADLs during a typical day. Use of a power wheelchair must significantly improve the beneficiary's ability to participate in MRADLs and the beneficiary will use it in the home (for severe cognitive/physical impairments, participation in MRADLs may require caregiver assistance), and the beneficiary has not expressed an unwillingness to use a power wheelchair in the home. For a Group 2 standard PWC, a Group 2 PWC (K0820, K0821, K0822, K0823, K0824, K0825, K0826, K0827, K0828, K0829) is covered if all of the coverage criteria (a)-(e) for a PWC are met and the wheelchair is appropriate for the beneficiary's weight. For a Group 2 Single Power Option PWC, all coverage criteria (a)-(e) must be met, plus the beneficiary meets coverage criteria for a power tilt or recline seating system OR requires a drive control interface other than a hand or chin-operated standard proportional joystick (examples include head control, sip and puff, switch control) , and a specialty evaluation must be performed by a licensed/certified medical professional (PT, OT, or practitioner with rehab wheelchair training) with no financial relationship with the supplier, and the wheelchair must be provided by a supplier that employs a RESNA-certified Assistive Technology Professional (ATP) with direct, in-person involvement in the wheelchair selection. DME has a reasonable useful lifetime (RUL) of 5 years , and payment is made for only one wheelchair at a time; backup chairs are denied as not reasonable and necessary.

- **Document MRADL impact in detail**: Provide a clinician note specifying which MRADLs (toileting, feeding, dressing, grooming, bathing) the patient cannot complete or completes only with heightened morbidity/mortality risk, directly mapping to the LCD L33789 definition of a qualifying mobility limitation . - **Stepwise rule-out of lesser devices**: Submit PT/OT documentation explaining why a cane, walker, and optimally-configured manual wheelchair each fail — addressing strength, endurance, ROM, coordination, pain, or upper-extremity deformity per the LCD's enumerated upper-extremity assessment factors (strength, endurance, range of motion, coordination, pain, deformity or absence of one or both upper extremities) . - **Provide compliant face-to-face and WOPD**: Attach the dated face-to-face mobility examination note and the signed Standard Written Order before delivery; cite Final Rule 1713's requirement of a face-to-face encounter and Written Order Prior to Delivery as satisfied. - **Include RESNA ATP and independent specialty evaluation**: For Group 2 Single Power Option chairs, include both the ATP credential attestation and the independent PT/OT specialty evaluation, satisfying the requirement that a licensed PT/OT with no financial relationship to the supplier perform the specialty evaluation and that a RESNA-certified ATP have direct involvement in wheelchair selection . - **Demonstrate in-home use**: Document home assessment showing adequate access between rooms and maneuvering space, and explicitly state the device will be used in the home to meet the requirement that the beneficiary's home provides adequate access and that the power wheelchair will significantly improve the beneficiary's ability to participate in MRADLs in the home . - **Justify Group 2 over Group 1**: If denied as needing only a Group 1, document the patient's weight against capacity limits or, for Single Power Option, the medical necessity of power tilt/recline (e.g., pressure ulcer risk, inability to perform a functional weight shift) or alternative drive control interface per LCD L33789 Group 2 Single Power Option criteria including need for non-standard drive control such as head control, sip and puff, or switch control . - **Replacement vs. repair**: For replacement requests, document the 5-year RUL and that the existing chair cannot be repaired or no longer meets the patient's needs, citing the 5-year reasonable useful lifetime standard and UHC's allowance for upgrades when the member's condition changes (e.g., impaired function necessitates an upgrade to a power wheelchair from a manual one) .

## Why UnitedHealthcare Denied Your Group 2 Power Wheelchair for "Prior Authorization Required"

Prior authorization (PA) denials for Group 2 power wheelchairs are among the most common DME denials UnitedHealthcare issues. A PA-required denial does not mean the wheelchair is not covered — it means UHC did not receive or approve a pre-authorization request before the equipment was ordered or delivered. This is a procedural denial, and the underlying coverage may be fully intact.

## Why This Denial Is Appealable

If authorization was sought and either not processed correctly or denied without a thorough clinical review, you have grounds for appeal. If the chair was prescribed in an urgent or emergency situation where obtaining prior authorization was not practicable, federal and most state laws provide protections. Even a retroactive PA request may succeed when supported by proper clinical documentation.

## Federal Appeal Framework

• Internal appeal: File under ERISA §503 (employer plans) or applicable state law. The deadline is on your EOB — do not miss it.
• External review: Available under ACA §2719 after final internal denial. An independent reviewer will assess whether UHC's PA process and decision were consistent with your plan terms and applicable clinical standards.
• Expedited option: If your mobility needs make waiting harmful, request expedited review at both the internal and external stages.
• Window: You generally have up to four months from a final adverse decision to request external review.

## Concrete Appeal Steps

1. Obtain the original PA submission records and UHC's denial rationale. 2. Confirm whether a PA was submitted — if not, determine whether a retroactive authorization request is permitted under your plan. 3. Gather complete clinical documentation (see below) and resubmit or appeal. 4. Request a peer-to-peer review between UHC's medical reviewer and your prescribing physician if your plan allows it. 5. File external review if internal appeal is unsuccessful.

## Documentation to Gather

• Physician diagnosis records establishing the qualifying mobility condition
• Functional mobility assessment by a qualified therapist or physiatrist
• Documentation of prior wheelchair use history and why a Group 2 power wheelchair is now required
• Prescriber letter of medical necessity referencing UHC's coverage criteria
• Records of any prior authorization submission (confirmation numbers, dates, correspondence)

## Criteria-Mapping Structure

Obtain UHC's current coverage policy for Group 2 power wheelchairs. List each criterion. For each criterion, provide the corresponding dated chart entry or clinical note that satisfies it. This structured mapping is the most effective way to demonstrate medical necessity and overcome a PA-related denial at both the internal and external review stages.